Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-9980|4|12|JAHA.115.002015-JAHA.115.002015

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.4, Iss.12, 2015-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chapter 10: Stroke Prevention in Atrial Fibrillation and Other Cardiac Sources of Embolism

By  

Cerebrovascular Diseases, Vol. 9, Iss. 4, 1999-08 ,pp. : 53-61

Karger

Access to resources Recommend Favorite

Is Atrial Fibrillation Always a Culprit of Stroke in Patients with Atrial Fibrillation plus Stroke?

By  

Cerebrovascular Diseases, Vol. 36, Iss. 5-6, 2013-11 ,pp. : 373-382

Karger

Access to resources Recommend Favorite

Atrial Fibrillation and Stroke

By  

Cerebrovascular Diseases, Vol. 10, Iss. 4, 2000-10 ,pp. : 40-41

Karger

Access to resources Recommend Favorite

Age and Risk of Stroke in Atrial Fibrillation: Evidence for Guidelines?

By  

Neuroepidemiology, Vol. 28, Iss. 2, 2007-04 ,pp. : 109-115

Karger

Access to resources Recommend Favorite

Detection of Paroxysmal Atrial Fibrillation in Acute Stroke Patients

By  

Cerebrovascular Diseases, Vol. 30, Iss. 4, 2010-08 ,pp. : 410-417

Karger

Access to resources Recommend Favorite